Author
Listed:
- Joonseok Cho
(University of Florida College of Medicine)
- Yujian Zhang
(Otsuka Maryland Medicinal Laboratories)
- Shi-Young Park
(Korea Mouse Metabolic Phenotyping Center, Lee Gil Ya Cancer and Diabetes Institute, Gachon University School of Medicine)
- Anna-Maria Joseph
(University of Florida College of Medicine)
- Chul Han
(University of Florida College of Medicine)
- Hyo-Jin Park
(University of Florida College of Medicine)
- Srilaxmi Kalavalapalli
(University of Florida College of Medicine)
- Sung-Kook Chun
(University of Florida College of Medicine)
- Drake Morgan
(University of Florida College of Medicine)
- Jae-Sung Kim
(University of Florida College of Medicine)
- Shinichi Someya
(University of Florida College of Medicine)
- Clayton E. Mathews
(University of Florida College of Medicine)
- Young Jae Lee
(Korea Mouse Metabolic Phenotyping Center, Lee Gil Ya Cancer and Diabetes Institute, Gachon University School of Medicine)
- Stephanie E. Wohlgemuth
(University of Florida College of Medicine)
- Nishanth E. Sunny
(University of Florida College of Medicine)
- Hui-Young Lee
(Korea Mouse Metabolic Phenotyping Center, Lee Gil Ya Cancer and Diabetes Institute, Gachon University School of Medicine)
- Cheol Soo Choi
(Korea Mouse Metabolic Phenotyping Center, Lee Gil Ya Cancer and Diabetes Institute, Gachon University School of Medicine
Endocrinology, Internal Medicine, Gachon University Gil Medical Center)
- Takayuki Shiratsuchi
(Otsuka Maryland Medicinal Laboratories)
- S. Paul Oh
(University of Florida College of Medicine)
- Naohiro Terada
(University of Florida College of Medicine)
Abstract
Non-alcoholic fatty liver disease (NAFLD) is a common metabolic disorder in obese individuals. Adenine nucleotide translocase (ANT) exchanges ADP/ATP through the mitochondrial inner membrane, and Ant2 is the predominant isoform expressed in the liver. Here we demonstrate that targeted disruption of Ant2 in mouse liver enhances uncoupled respiration without damaging mitochondrial integrity and liver functions. Interestingly, liver specific Ant2 knockout mice are leaner and resistant to hepatic steatosis, obesity and insulin resistance under a lipogenic diet. Protection against fatty liver is partially recapitulated by the systemic administration of low-dose carboxyatractyloside, a specific inhibitor of ANT. Targeted manipulation of hepatic mitochondrial metabolism, particularly through inhibition of ANT, may represent an alternative approach in NAFLD and obesity treatment.
Suggested Citation
Joonseok Cho & Yujian Zhang & Shi-Young Park & Anna-Maria Joseph & Chul Han & Hyo-Jin Park & Srilaxmi Kalavalapalli & Sung-Kook Chun & Drake Morgan & Jae-Sung Kim & Shinichi Someya & Clayton E. Mathew, 2017.
"Mitochondrial ATP transporter depletion protects mice against liver steatosis and insulin resistance,"
Nature Communications, Nature, vol. 8(1), pages 1-12, April.
Handle:
RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms14477
DOI: 10.1038/ncomms14477
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms14477. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.